Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
J Gen Intern Med ; 35(10): 3077-3080, 2020 Oct.
Article in English | MEDLINE | ID: covidwho-680288

ABSTRACT

BACKGROUND: Most patients infected with SARS-CoV-2 have mild to moderate symptoms manageable at home; however, up to 20% develop severe illness requiring additional support. Primary care practices performing population management can use these tools to remotely assess and manage COVID-19 patients and identify those needing additional medical support before becoming critically ill. AIM: We developed an innovative population management approach for managing COVID-19 patients remotely. SETTING: Development, implementation, and evaluation took place in April 2020 within a large urban academic medical center primary care practice. PARTICIPANTS: Our panel consists of 40,000 patients. By April 27, 2020, 305 had tested positive for SARS-CoV-2 by RT-qPCR. Outreach was performed by teams of doctors, nurse practitioners, physician assistants, and nurses. PROGRAM DESCRIPTION: Our innovation includes an algorithm, an EMR component, and a twice daily population report for managing COVID-19 patients remotely. PROGRAM EVALUATION: Of the 305 patients with COVID-19 in our practice at time of submission, 196 had returned to baseline; 54 were admitted to hospitals, six of these died, and 40 were discharged. DISCUSSION: Our population management strategy helped us optimize at-home care for our COVID-19 patients and enabled us to identify those who require inpatient medical care in a timely fashion.


Subject(s)
Coronavirus Infections/therapy , Pneumonia, Viral/therapy , Primary Health Care/organization & administration , Telemedicine/organization & administration , Academic Medical Centers , Betacoronavirus , COVID-19 , Coronavirus Infections/epidemiology , Hospitalization/statistics & numerical data , Humans , Pandemics , Pneumonia, Viral/epidemiology , Program Development , Program Evaluation , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL